These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35856204)

  • 21. Retention of neutralizing antibodies to Japanese encephalitis vaccine in age groups above fifteen years in Korea.
    Lee HJ; Choi H; Park KH; Jang Y; Hong YJ; Kim YB
    Int J Infect Dis; 2020 Nov; 100():53-58. PubMed ID: 32829050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.
    Liu W; Clemens JD; Kari K; Xu ZY
    Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
    Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
    Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
    Khan SA; Choudhury P; Kakati S; Doley R; Barman MP; Murhekar MV; Kaur H
    Vaccine; 2021 Aug; 39(35):4973-4978. PubMed ID: 34325931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge, attitudes and practices of caregivers regarding Japanese encephalitis in Shaanxi Province, China.
    Zhang S; Yin Z; Suraratdecha C; Liu X; Li Y; Hills S; Zhang K; Chen Y; Liang X
    Public Health; 2011 Feb; 125(2):79-83. PubMed ID: 21288546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effectiveness of National Expanded Program on Immunization With Hepatitis A Vaccines in the Chinese Mainland: Interrupted Time-Series Analysis.
    Ming BW; Li L; Huang HN; Ma JJ; Shi C; Xu XH; Yang Z; Ou CQ
    JMIR Public Health Surveill; 2024 Feb; 10():e53982. PubMed ID: 38416563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving community coverage of Japanese encephalitis vaccination: lessons learned from a mass campaign in Battambang Province, Cambodia.
    Thigpen MC; Sarath S; Soeung SC; Vichit O; Kitsutani P; Sandhu H; Gregory C; Fischer M; Morn C; Hills SL
    BMC Public Health; 2022 Dec; 22(1):2244. PubMed ID: 36456999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Japanese encephalitis surveillance in China (Province of Taiwan) during 1968-1971. II. Age-secific incidence in connection with Japanese encephalitis vaccination program.
    Okuno T; Tseng PT; Hsu ST; Huang CT; Kuo CC
    Jpn J Med Sci Biol; 1975; 28(5-6):255-67. PubMed ID: 180320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia.
    Touch S; Suraratdecha C; Samnang C; Heng S; Gazley L; Huch C; Sovann L; Chhay CS; Soeung SC
    Vaccine; 2010 Jun; 28(29):4593-9. PubMed ID: 20470803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese encephalitis surveillance and immunization--Asia and the Western Pacific, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):658-62. PubMed ID: 23965828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of Japanese encephalitis among adults 40 years of age or older in northern China: Epidemiological and clinical characteristics.
    Wu D; Chen X; Liu W; Fu S; Li F; Liang G; Yang G; Zheng H; Li J; Yin Z; Li Y; Wang H
    Transbound Emerg Dis; 2021 Nov; 68(6):3415-3423. PubMed ID: 33283432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of Japanese encephalitis, southern China.
    Feng Y; Fu S; Zhang H; Petersen LR; Zhang B; Gao X; Yang W; Zhang Y; Dao B; Li K; Li N; Yin Z; Liu Y; Nasci R; Wang H; Liang G
    Emerg Infect Dis; 2013 Apr; 19(4):672-3. PubMed ID: 23750863
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiological characteristics of Japanese encephalitis in Guizhou Province, China, 1971-2009.
    Zhang L; Luan RS; Jiang F; Rui LP; Liu M; Li YX; Yin ZD; Luo HM
    Biomed Environ Sci; 2012 Jun; 25(3):297-304. PubMed ID: 22840580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese Encephalitis Vaccine.
    Mileno MD
    R I Med J (2013); 2020 Aug; 103(6):49-50. PubMed ID: 32752568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Travel-acquired Japanese encephalitis and vaccination considerations.
    Pavli A; Maltezou HC
    J Infect Dev Ctries; 2015 Sep; 9(9):917-24. PubMed ID: 26409731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012.
    Liu Y; Lin H; Zhu Q; Wu C; Zhao Z; Zheng H
    Vaccine; 2014 Mar; 32(15):1768-73. PubMed ID: 24503272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence of Japanese encephalitis epidemic in Wuhan, China, 2009-2010.
    Hu Q; Chen B; Zhu Z; Tian J; Zhou Y; Zhang X; Zheng X
    PLoS One; 2013; 8(1):e52687. PubMed ID: 23326348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.